Seres Therapeutics, Inc. (MCRB) is a publicly traded Healthcare sector company. As of October 15, 2026, MCRB trades at $2.49 with a market cap of $25.41M and a P/E ratio of -1.20. MCRB moved +2.81% today. Year to date, MCRB is -84.03%; over the trailing twelve months it is -87.72%. Its 52-week range spans $2.39 to $29.98. Analyst consensus is buy with an average price target of $17.00. Rallies surfaces MCRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for MCRB combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.49 |
| Market Cap | $25.41M |
| P/E Ratio | -1.20 |
| EPS | $-2.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.98 |
| 52-Week Low | $2.39 |
| Volume | 244 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.88M |
| Net Income | $-22.46M |
| Gross Margin | 0.00% |
2 analysts cover MCRB: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.00.